Report: New Jersey's biotech sector faces challenges amid growth

09/15/2008 | NJBIZ (New Jersey)

The biotech industry in New Jersey has grown despite a sluggish economy and interruptions in global credit markets, according to a report from trade group BioNJ and accounting company Ernst & Young. The sector's continued development, however, could be hampered by dwindling early-stage financing, high operating expenses and other problems, the report said.

View Full Article in:

NJBIZ (New Jersey)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN